Cecil Farrington
Family Medicine · Salisbury, NCNPI 1114913134
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,298 of the $6,219 with a category attached, or 85.2%. It is spread thinly across 25 manufacturers, the largest accounting for just 20.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $2,639 and has fallen 99.4% since, to $15 in 2024. Among family medicine clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 192 payments — averaging $32.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- Merck$1K
- AstraZeneca$880
- AbbVie$555
- Johnson & Johnson$486
- Lilly USA, LLC$377
- plus $2K from 19 others
Across 530 payments — averaging $11,975 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$4.9M
- AbbVie$602K
- Merck$424K
- GSK$159K
- AstraZeneca$115K
- Regeneron$103K
- plus $56K from 3 others
What the payments were for
- Travel & lodging$90114%
- Food & beverage$5,29885%
- Gifts$200%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 33 | $1,241 |
| Merck | 9 | $1,119 |
| AstraZeneca | 16 | $880 |
| AbbVie | 25 | $555 |
| Johnson & Johnson | 13 | $486 |
| Lilly USA, LLC | 18 | $377 |
| Boehringer Ingelheim | 9 | $337 |
| Sanofi-aventis U.S. LLC | 8 | $190 |
| Amgen | 8 | $160 |
| Novartis | 12 | $142 |
| GSK | 8 | $125 |
| Pfizer | 9 | $124 |
| Biohaven Pharmaceuticals, Inc. | 1 | $79 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $75 |
| Bayer | 5 | $75 |
| Abbott | 4 | $74 |
| E.r. Squibb & Sons, L.L.C. | 2 | $27 |
| Hologic Sales And Service, LLC | 1 | $26 |
| Ironwood Pharmaceuticals, Inc | 1 | $23 |
| Si-bone, Inc. | 1 | $21 |
| Lundbeck LLC | 1 | $21 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
| Mylan Pharmaceuticals Inc. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GARDASIL 9$773
- FARXIGA$132
- BREZTRI$125
- RYBELSUS$104
How this compares
$6,219 in reported general payments places this provider in the 90th percentile of 3,444 family medicine providers in North Carolina.
Other family medicine in Salisbury
- Parinda FruchtmanSalisbury$16K
- William CromwellRaleigh$879K
- Steve VacalisGastonia$693K
- David DundeeWinston Salem$633K
- Kevin SodenCharlotte$558K
- Brian ForrestApex$398K
- Joseph KonenCharlotte$322K
- Richard RachimaCharlotte$294K
- Dimitrios HondrosCharlotte$275K
- Domingo Rodriguez-CueGarner$253K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.